SPI Pharmaceuticals: The Costa Mesa drug company...

SPI Pharmaceuticals: The Costa Mesa drug company said profit for the first quarter nearly doubled to $8.4 million, or 41 cents a share, from $5.7 million, or 29 cents a share, for the same period last year. Sales dropped 40%, however, to $72.2 million from $119.6 million. The company attributed the decline to lower sales in Yugoslavia.